Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FABOLUS-FASTER STEMI facilitation trial
2017-001065-24Phase 3Completed
- Sponsor
- Insel Gruppe
- Start
- Nov 2020
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cangrelor, tirofiban, prasugrel in myocardial infarction (MI), acute ST-segment elevation myocardial infarction (STEMI), sponsored by Insel Gruppe. Started Nov 2020; status: completed.
02
Drugs
cangrelortirofibanprasugrel
03
Conditions
myocardial infarction (MI)acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on 2017-001065-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001065-24.